Fresenius SE Net Income 2016-2024 | FSNUY
Fresenius SE net income from 2016 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Fresenius SE Annual Net Income
(Millions of US $) |
| 2023 |
$-643 |
| 2022 |
$1,446 |
| 2021 |
$2,151 |
| 2020 |
$1,950 |
| 2019 |
$2,109 |
| 2018 |
$2,392 |
| 2017 |
$2,050 |
| 2016 |
$1,763 |
| 2015 |
$1,507 |
Fresenius SE Quarterly Net Income
(Millions of US $) |
| 2024-09-30 |
$358 |
| 2024-06-30 |
$-402 |
| 2024-03-31 |
$302 |
| 2023-12-31 |
$-660 |
| 2023-09-30 |
$-442 |
| 2023-06-30 |
$87 |
| 2023-03-31 |
$371 |
| 2022-12-31 |
$251 |
| 2022-09-30 |
$323 |
| 2022-06-30 |
$408 |
| 2022-03-31 |
$463 |
| 2021-12-31 |
$572 |
| 2021-09-30 |
$487 |
| 2021-06-30 |
$568 |
| 2021-03-31 |
$524 |
| 2020-12-31 |
$492 |
| 2020-09-30 |
$499 |
| 2020-06-30 |
$453 |
| 2020-03-31 |
$506 |
| 2019-12-31 |
$571 |
| 2019-09-30 |
$494 |
| 2019-06-30 |
$529 |
| 2019-03-31 |
$515 |
| 2018-12-31 |
$586 |
| 2018-09-30 |
$487 |
| 2018-06-30 |
$778 |
| 2018-03-31 |
$541 |
| 2017-12-31 |
$603 |
| 2017-09-30 |
$465 |
| 2017-06-30 |
$495 |
| 2017-03-31 |
$487 |
| 2016-12-31 |
$478 |
| 2016-09-30 |
$442 |
| 2016-06-30 |
$444 |
| 2016-03-31 |
$399 |
| 2015-12-31 |
$393 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$0.000B |
$23.628B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
